Moderna, Inc. (MRNA) NASDAQ

42.98

+2.87(+7.16%)

Updated at February 13 12:25PM

Currency In USD

Valuation

Market Cap11.47B
Enterprise Value11.47B
P/E Ratio-6
PEG Ratio0.84
Price/Sales Ratio8.68
Price/Book Ratio1.96
Enterprise/Revenue8
Enterprise/EBITDA-5.81

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-1.45
Operating Margin-1.58

Management Effectiveness

Return On Assets-0.23
Return On Equity-0.3

Income Statement

Revenue1.94B
Revenue/Share4.96
Gross Profit1.08B
EBITDA-3.07B
Net Income-2.82B
Diluted EPS-7.26

Balance Sheet

Total Cash2.6B
Total Cash/Share6.62
Total Debt1.26B
Total Debt/Equity0.15
Current Ratio3.29
Book Value Per Share22.07

Price History

52-Week Change35.33
52-Week High55.2
52-Week Low22.28
Moving Average 50 Days36.38
Moving Average 200 Days29.28

Statistics

Average Volume11.6M
Shares Outstanding390.73M
% Held by Institutions70.77

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A